|
104
|
315
|
2pdkA |
Human aldose reductase mutant l301m complexed with sorbinil. |
|
108
|
313
|
2pfhA |
Complex of aldose reductase with nadp+ and simaltaneously bound competetive inhibitors fidarestat and idd594. concentration of fidarestat in soaking solution is less than concentration of idd594. |
|
103
|
315
|
2pdhA |
Human aldose reductase mutant l300p complexed with uracil-type inhibitor at 1.45 a. |
|
101
|
315
|
2pdwA |
Human aldose reductase mutant c303d complexed with fidarestat. |
|
102
|
314
|
2pdfA |
Human aldose reductase mutant l300p complexed with zopolrestat. |
|
103
|
315
|
2pd9A |
Human aldose reductase mutant v47i complexed with fidarestat. |
|
105
|
315
|
2pdyA |
Human aldose reductase double mutant s302r-c303d complexed with fidarestat. |
|
107
|
314
|
2pdgA |
Human aldose reductase with uracil-type inhibitor at 1.42a. |
|
106
|
315
|
2pd5A |
Human aldose reductase mutant v47i complexed with zopolrestat |
|
111
|
316
|
2pznA |
The crystallographic structure of aldose reductase idd393 complex confirms leu300 as a specificity determinant |
|
114
|
316
|
2pevA |
Complex of aldose reductase with nadp+ and simaltaneously bound competetive inhibitors fidarestat and idd594. concentration of fidarestat in soaking solution exceeds concentration of idd594. |
|
105
|
315
|
2pdbA |
Human aldose reductase mutant f121p complexed with zopolrestat. |
|
110
|
313
|
2pf8A |
Complex of aldose reductase with nadp+ and simaltaneously bound competetive inhibitors fidarestat and idd594. concentration of fidarestat in soaking solution is equal to concentration of idd594. |
|
104
|
315
|
2pdcA |
Human aldose reductase mutant f121p complexed with idd393. |
|
105
|
315
|
2pdmA |
Human aldose reductase mutant s302r complexed with zopolrestat. |
|
102
|
315
|
2pduA |
Human aldose reductase mutant c303d complexed with idd393. |
|
103
|
315
|
2pdnA |
Human aldose reductase mutant s302r complexed with uracil-type inhibitor. |
|
106
|
315
|
2pdjA |
Human aldose reductase mutant l300a complexed with idd393. |
|
108
|
315
|
2nvcA |
Human aldose reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3) |
|
103
|
315
|
2inzA |
Crystal structure of aldose reductase complexed with 2-hydroxyphenylacetic acid |
|
100
|
314
|
2isfA |
Crystal structure of c298a w219y aldose reductase complexed with phenylacetic acid |
|
102
|
314
|
2ineA |
Crystal structure of aldose reductase complexed with phenylacetic acid |
|
112
|
316
|
2j8tA |
Human aldose reductase in complex with nadp and citrate at 0.82 angstrom |
|
103
|
315
|
2ikhA |
Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 a |
|
100
|
314
|
2iq0A |
Crystal structure of aldose reductase complexed with hexanoic acid |
|
101
|
315
|
2ikjA |
Human aldose reductase complexed with nitro-substituted idd-type inhibitor |
|
99
|
315
|
2is7A |
Crystal structure of aldose reductase complexed with dichlorophenylacetic acid |
|
93
|
314
|
2ipwA |
Crystal structure of c298a w219y aldose reductase complexed with dichlorophenylacetic acid |
|
98
|
315
|
2iqdA |
Crystal structure of aldose reductase complexed with lipoic acid |
|
106
|
311
|
2ikiA |
Human aldose reductase complexed with halogenated idd-type inhibitor |
|
110
|
313
|
2i16A |
Human aldose reductase in complex with nadp+ and the inhibitor idd594 at temperature of 15k |
|
104
|
316
|
2ikgA |
Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 a |
|
104
|
315
|
2hvnA |
Human aldose reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocryst) |
|
104
|
314
|
2hv5A |
Human aldose reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_3) |
|
106
|
315
|
2hvoA |
Human aldose reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst) |
|
110
|
313
|
2i17A |
Human aldose reductase in complex with nadp+ and the inhibitor idd594 at temperature of 60k |
|
108
|
316
|
2fzbA |
Human aldose reductase complexed with four tolrestat molecules at 1.5 a resolution. |
|
104
|
315
|
2fz8A |
Human aldose reductase complexed with inhibitor zopolrestat at 1.48 a(1 day soaking). |
|
110
|
313
|
2fzdA |
Human aldose reductase complexed with tolrestat at 1.08 a resolution. |
|
103
|
315
|
2fz9A |
Human aldose reductase complexed with inhibitor zopolrestat after six days soaking. |
|
97
|
315
|
2f2kA |
Aldose reductase tertiary complex with nadph and deg |
|
104
|
315
|
2duzA |
Human aldose reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2) |
|
105
|
315
|
2duxA |
Crystal structure of human aldose reductase complexed with zopolrestat after 3 days soaking (3days_soaked_1) |
|
110
|
314
|
2dv0A |
Human aldose reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2) |
|
110
|
308
|
2bgsA |
Holo aldose reductase from barley |
|
109
|
312
|
2bgqA |
Apo aldose reductase from barley |
|
102
|
315
|
2acrA |
An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose-6-phosphate |
|
110
|
316
|
2agtA |
Aldose reductase mutant leu 300 pro complexed with fidarestat |
|
99
|
314
|
2acsA |
An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose-6-phosphate |
|
102
|
315
|
2acuA |
Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and the crystal structure of the y48h mutant enzyme |
